✦ LIBER ✦

Targeted Therapy in Chronic Lymphocytic Leukemia: Past, Present, and Future

✍ Scribed by Danilov, Alexey V.

Book ID: 123390916
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 242 KB
Volume: 35
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2013.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incorporating Targeted Agents Into Futur

Incorporating Targeted Agents Into Future Therapy of Chronic Lymphocytic Leukemia

✍ Pallasch, Christian P.; Hallek, Michael 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 592 KB

Chronic myeloid leukemia—Past, present,

Chronic myeloid leukemia—Past, present, and future

✍ John Goldman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

First-line therapy for chronic myeloid l

First-line therapy for chronic myeloid leukemia: Past, present, and future

✍ Carolina Pavlovsky; Hagop Kantarjian; Jorge E. Cortes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

## Abstract The development of Bcr‐Abl tyrosine kinase inhibitors has dramatically changed the prognosis of patients with newly diagnosed chronic myeloid leukemia (CML). Standard‐dose imatinib (400 mg/day in chronic phase, 600 mg/day in advanced CML) now dominates the management of this disease, pr

[Advances in Experimental Medicine and B

[Advances in Experimental Medicine and Biology] Advances in Chronic Lymphocytic Leukemia Volume 792 || Towards Targeted Therapy of Chronic Lymphocytic Leukemia

✍ Malek, Sami 📂 Article 📅 2013 🏛 Springer New York ⚖ 499 KB

Antiviral therapy for chronic hepatitis

Antiviral therapy for chronic hepatitis C: past, present, and future

✍ Norio Hayashi; Tetsuo Takehara 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 220 KB

Antiviral therapy of chronic hepatitis B

Antiviral therapy of chronic hepatitis B: past, present, and future

✍ Perrillo, Robert P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 785 KB